Three weeks have elapsed since we last took up the issue of target-date and other fund-of-funds vehicles. So we thought it was about time to take another crack at these things. Today's object lesson: Vanguard's Target Retirement 2050 Fund.
We have three primary objections to these instruments:
We'd add high explicit and implicit expenses, but that's a problem with mutual funds in general, not target-date funds in particular.
So how does the Vanguard 2050 Fund stack up? First, we want to be very clear about this: Vanguard is about as client-friendly as an outfit can be. The company's long-standing commitment to low-cost, low-BS investing has given it a fully-deserved reputation as an industry leader.
And on the question of expenses, Vanguard's 2050 Fund's 0.21% expense ratio is absurdly cheap. No problem there. But as we've mentioned in this space, low costs are just one (very important) part of the equation. The other part? Getting the investment strategy--the asset allocation, the rebalancing, the choice of investment vehicles--as right as one can get it. In other words, we'd rather have an optimal mix of investment with slightly higher costs than a sub-optimal mix at rock-bottom costs...because the (negative) compounded "cost" of having the wrong mix can far exceed the (positive) compounded effects of lower expenses.
We can't speak to Vanguard's rebalancing process at the moment (because we're having a heck of a time opening the prospectus...we'll try again later). And Vanguard 2050 clearly isn't stuffed full of under-performing, unsellable proprietary funds. So that leaves us with the fund's asset allocation. Let's take a look...
Now, our most aggressive portfolios don't include any fixed-income positions, but a 10% allocation to the asset class is a relatively minor quibble. We would point out that we think any long-term fixed-income exposure must include some non-U.S. exposure, preferably including emerging markets debt.
But let's focus on the most glaring fact here: With roughly half of global market cap existing outside the U.S., one of the world's greatest indexing shops--a shop, in other words, that places great emphasis on market cap per se--wants its youngest, most aggressive investors to have less than 20% exposure to non-U.S. equities, less than 4% of which is in emerging markets, where, whatever short- and medium-term volatility may pop up from time to time, long-term growth prospects far outstrip the developed markets.
In addition, to break away from established cap-weighting, one might want a little more exposure to small- and mid-cap equities, both domestic and international. Here again, a supposedly evidence-based operation, by leaning overwhelmingly on its Total Stock Market Index Fund, denies its passive, long-term investors the opportunity to benefit from the long-term outperformance of smaller-cap stocks.** Of course the Total Stock Market fund does provide some exposure to small-cap equities, but shouldn't long-term investors have at least a marginal overweight in the asset class? We think so. Vanguard, apparently, does not.
Here's our point: Target-date funds are elegant in their simplicity and, in Vanguard's case, in their low costs of ownership. But too many target-date funds, even those provided by investor-friendly shops like T. Rowe Price and Vanguard, suffer from problematic investment mandates that seem likely to keep their shareholders from enjoying the full benefits of a long-term, pension-caliber investment.
One might wonder why this is the case. After all, these outfits employ some of the brightest, best-educated, most sophisticated minds in the business. This is unadulterated speculation, and we offer it very guardedly, but if one "follows the money," one might suspect that fund providers might prefer lower short-term volatility (whatever the implications for long-term returns might be) to the alternative of higher short-term volatility, which might shake shareholders, and the fees they pay, out of the funds in question.
If anyone has a different theory, we'd love to hear about it.
~~~~~~~~~~~~~~~~
*Why? Often because the fund company has a tough time selling its inferior funds outside the outwardly desirable and increasingly popular target-date framework. Just another example of Wall Street's sales objectives trumping investor interests...
**Yes, that outperformance is historical, and may not repeat itself. But the the same thing can be said for the benefits of indexing, which, in general, we celebrate. Ultimately, history--and a little theory--is all we have to work with, and it provides a perfectly sensible rationale for overweighting small- and mid-cap stocks, especially small-cap value stocks, in any long-term portfolio.